Literature DB >> 28817744

Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.

N Venkatesh Prajna1, Tiruvengada Krishnan1, Revathi Rajaraman1, Sushila Patel2, Ranjeet Shah3, Muthiah Srinivasan1, Manoranjan Das1, Kathryn J Ray4, Catherine E Oldenburg4, Stephen D McLeod4,5, Michael E Zegans6, Nisha R Acharya4,5,7, Thomas M Lietman4,5,7, Jennifer Rose-Nussbaumer4,5.   

Abstract

Importance: Identifying patients with infectious keratitis who are at risk of experiencing a poor outcome may be useful to allocate resources toward high-risk patients, particularly in resource-poor settings. Objective: To determine baseline patient and ulcer characteristics that predict a high risk of developing corneal perforation and/or the need to undergo therapeutic penetrating keratoplasty (TPK). Design, Setting, and Participants: This is a secondary analysis of Mycotic Ulcer Treatment Trial II, a multicenter, double-masked, placebo-controlled randomized clinical trial that enrolled 240 patients with smear-positive filamentous fungal corneal ulcers who enrolled between May 2010 and August 2015. Participants had a baseline visual acuity of 20/400 or worse and were randomized to receive oral voriconazole or a placebo (all participants received topical voriconazole, 1%). After 39 participants (16.3%) were enrolled, topical natamycin, 5%, was also added. Main Outcomes and Measures: The primary outcome of this secondary analysis was the rate of corneal perforation or the need to undergo TPK.
Results: The mean (SD) age at enrollment was 49 (13) years, 104 participants (43.3%) were women, and all were of Southeast Asian descent. The presence of hypopyon at baseline indicated 2.28 times the odds of the patient developing corneal perforation and/or needing TPK (95% CI, 1.18-4.40; P = .01). Study participants whose infiltrate involved the posterior one-third had a 71.4% risk of developing corneal perforation and/or needing TPK. For each 1-mm increase in the geometric mean of the infiltrate, there was 1.37 (95% CI, 1.12-1.67; P = .002) increased odds of developing perforation and/or needing TPK. Other clinical features such as visual acuity, baseline culture positivity, type of filamentous fungal organism and duration of symptoms, and demographic characteristics, such as sex and occupation, were not significant predictors in the multivariable regression analysis. Conclusions and Relevance: These results suggest that risk stratification from baseline ulcer characteristics can identify those at highest risk for developing corneal perforation and/or needing TPK. Trial Registration: clinicaltrials.gov Identifier: NCT00996736.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28817744      PMCID: PMC6038821          DOI: 10.1001/jamaophthalmol.2017.2914

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  13 in total

1.  Corneal ulceration in the developing world--a silent epidemic.

Authors:  J P Whitcher; M Srinivasan
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Therapeutic surgery in failures of medical treatment for fungal keratitis.

Authors:  R K Forster; G Rebell
Journal:  Br J Ophthalmol       Date:  1975-07       Impact factor: 4.638

3.  Penetrating Keratoplasty at a Tertiary Referral Center in Ethiopia: Indications and Outcomes.

Authors:  Menen Ayalew; Yonas Tilahun; Doug Holsclaw; Maanasa Indaram; Nicole E Stoller; Jeremy D Keenan; Jennifer Rose-Nussbaumer
Journal:  Cornea       Date:  2017-06       Impact factor: 2.651

4.  Risk factors in microbial keratitis leading to penetrating keratoplasty.

Authors:  A I Miedziak; M R Miller; C J Rapuano; P R Laibson; E J Cohen
Journal:  Ophthalmology       Date:  1999-06       Impact factor: 12.079

5.  Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.

Authors:  N Venkatesh Prajna; Tiruvengada Krishnan; Revathi Rajaraman; Sushila Patel; Muthiah Srinivasan; Manoranjan Das; Kathryn J Ray; Kieran S O'Brien; Catherine E Oldenburg; Stephen D McLeod; Michael E Zegans; Travis C Porco; Nisha R Acharya; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  JAMA Ophthalmol       Date:  2016-12-01       Impact factor: 7.389

6.  Results of therapeutic penetrating keratoplasty for bacterial and fungal keratitis.

Authors:  Yusuf Koçluk; Emine Alyamaç Sukgen
Journal:  Int Ophthalmol       Date:  2016-10-08       Impact factor: 2.031

7.  Outcomes of therapeutic penetrating keratoplasty from a tertiary eye care centre in northern India.

Authors:  Namrata Sharma; Mohit Jain; Sri V Sehra; Prafulla Maharana; Tushar Agarwal; Gita Satpathy; Rasik B Vajpayee
Journal:  Cornea       Date:  2014-02       Impact factor: 2.651

8.  Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.

Authors:  Jennifer Rose-Nussbaumer; N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kieran S O'Brien; Kathryn J Ray; Travis C Porco; Stephen D McLeod; Nisha R Acharya; Jeremy D Keenan; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2015-11-03       Impact factor: 4.638

9.  Evaluation of agent and host factors in progression of mycotic keratitis: A histologic and microbiologic study of 167 corneal buttons.

Authors:  Geeta Kashyap Vemuganti; Prashant Garg; Usha Gopinathan; Thomas J Naduvilath; Rajesh K John; Rajeev Buddi; Gullapalli N Rao
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

10.  Outcome of therapeutic penetrating keratoplasty in a tertiary eye care center in Nepal.

Authors:  Leena Bajracharya; Reeta Gurung
Journal:  Clin Ophthalmol       Date:  2015-12-07
View more
  9 in total

1.  The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.

Authors:  Kathryn J Ray; N Venkatesh Prajna; Prajna Lalitha; Revathi Rajaraman; Tiruvengada Krishnan; Sushila Patel; Manoranjan Das; Ranjeet Shah; Kavita Dhakhwa; Stephen D McLeod; Michael E Zegans; Nisha R Acharya; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  Am J Ophthalmol       Date:  2018-02-10       Impact factor: 5.258

Review 2.  Fungal keratitis: Mechanisms of infection and management strategies.

Authors:  Christopher Donovan; Eduardo Arenas; Ramesh S Ayyala; Curtis E Margo; Edgar M Espana
Journal:  Surv Ophthalmol       Date:  2021-08-20       Impact factor: 6.197

3.  Individualized Corneal Patching for Treatment of Corneal Trauma Combined with Tissue Defects.

Authors:  Ting Zhang; Yanni Jia; Suxia Li; Weiyun Shi
Journal:  J Ophthalmol       Date:  2020-11-23       Impact factor: 1.909

4.  A Case of Recurrent Fungal Keratitis Post-Amniotic Membrane Transplantation for Corneal Perforation.

Authors:  Rina Soda; Hideki Fukuoka; Chie Sotozono
Journal:  Case Rep Ophthalmol       Date:  2022-03-17

5.  Therapeutic and tectonic keratoplasty with simple cryopreserved remnants of donor corneas: an 11 year retrospective case series.

Authors:  Jae-Gon Kim; Jong Hwa Jun
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

6.  An Interpretable and Expandable Deep Learning Diagnostic System for Multiple Ocular Diseases: Qualitative Study.

Authors:  Kai Zhang; Xiyang Liu; Fan Liu; Lin He; Lei Zhang; Yahan Yang; Wangting Li; Shuai Wang; Lin Liu; Zhenzhen Liu; Xiaohang Wu; Haotian Lin
Journal:  J Med Internet Res       Date:  2018-11-14       Impact factor: 5.428

7.  Clinical Characteristics and Outcomes of Fungal Keratitis in the United Kingdom 2011-2020: A 10-Year Study.

Authors:  Darren Shu Jeng Ting; Mohamed Galal; Bina Kulkarni; Mohamed S Elalfy; Damian Lake; Samer Hamada; Dalia G Said; Harminder S Dua
Journal:  J Fungi (Basel)       Date:  2021-11-12

8.  Clinical analysis of fungal keratitis in patients with and without diabetes.

Authors:  Jing Dan; Qingjun Zhou; Hualei Zhai; Jun Cheng; Lei Wan; Cheng Ge; Lixin Xie
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

9.  Commentary: Timing of therapeutic keratoplasty.

Authors:  N Venkatesh Prajna; Komal Sangoi
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.